Despite some significant clinical-trial challenges, focus remains high in industry on developing devices to treat hypertension. US FDA is looking to stay ahead of the progress with a newly scheduled Dec. 5 meeting of its Circulatory System Devices Panel.
"Clinical studies to evaluate the safety and effectiveness of these devices are progressing," the agency said in the Oct. 26 meeting notice. "FDA requests panel input regarding the potential indications...